The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach (TAPIR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01940094 |
|
Recruitment Status :
Recruiting
First Posted : September 11, 2013
Last Update Posted : October 12, 2022
|
Sponsor:
University of Pennsylvania
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Office of Rare Diseases (ORD)
National Center for Advancing Translational Sciences (NCATS)
Rare Diseases Clinical Research Network
Information provided by (Responsible Party):
Peter Merkel, University of Pennsylvania
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2023 |
| Estimated Study Completion Date : | December 2023 |